Display Settings:

Format

Send to:

Choose Destination
    Neurobiol Aging. 2013 May;34(5):1519.e5-1519.e12. doi: 10.1016/j.neurobiolaging.2012.10.003. Epub 2012 Oct 27.

    Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians.

    Source

    John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, USA. Electronic address: mkohli@med.miami.edu.

    Abstract

    Recently, a hexanucleotide repeat expansion in the C9ORF72 gene has been identified to account for a significant portion of Caucasian families affected by frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Given the clinical overlap of FTD with Alzheimer's disease (AD), we hypothesized that C9ORF72 expansions might contribute to AD. In Caucasians, we found C9ORF72 expansions in the pathogenic range of FTD/ALS (>30 repeats) at a proportion of 0.76% in AD cases versus 0 in control subjects (p = 3.3E-03; 1182 cases, 1039 controls). In contrast, no large expansions were detected in individuals of African American ethnicity (291 cases, 620 controls). However, in the range of normal variation of C9ORF72 expansions (0-23 repeat copies), we detected significant differences in distribution and mean repeat counts between Caucasians and African Americans. Clinical and pathological re-evaluation of identified C9ORF72 expansion carriers revealed 9 clinical and/or autopsy confirmed AD and 2 FTD final diagnoses. Thus, our results support the notion that large C9ORF72 expansions lead to a phenotypic spectrum of neurodegenerative disease including AD.

    Copyright © 2013 Elsevier Inc. All rights reserved.

    PMID:
    23107433
    [PubMed - in process]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk